0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Human Health Effects Nanoplastics Remediation Sign in to save

Mitochondrial Dysfunction and Nanocarrier-Based Treatments in Chronic Obstructive Pulmonary Disease (COPD)

Oxygen 2023 8 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 50 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Kiyoshi Sato, Hiroyoshi Kawakami

Summary

This review examines how mitochondrial dysfunction contributes to the development and progression of chronic obstructive pulmonary disease. Researchers highlight emerging nanocarrier-based drug delivery systems designed to target mitochondrial dysfunction in lung tissue. The study suggests these novel nanoparticle approaches, while still in early clinical stages, represent a promising direction for future treatments.

Body Systems

Mitochondrial dysfunction significantly contributes to the pathogenesis and progression of chronic obstructive pulmonary disease (COPD). To treat mitochondrial dysfunction in COPD, novel drug delivery systems (DDS) are needed. In this review, we provide a brief overview of the current understanding of the factors in COPD and highlight the trends in novel nanocarriers/nanoparticles for targeting mitochondrial dysfunction. These drug-encapsulated nanoparticles are still in the early stages of clinical application but represent the most promising system for COPD therapy.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Environmental nanoplastics induce mitochondrial dysfunction: A review of cellular mechanisms and associated diseases

This review summarizes how nanoplastics, which are small enough to enter individual cells, damage mitochondria (the energy-producing structures inside cells) by disrupting their shape, function, and ability to produce energy. This mitochondrial damage has been linked to a range of diseases including neurodegeneration, diabetes, cardiovascular disease, and reproductive problems. The findings help explain why nanoplastic exposure may contribute to multiple chronic health conditions through a common cellular mechanism.

Article Tier 2

Assessing micro and nanoplastics toxicity using rodent models: Investigating potential mitochondrial implications

This review examines recent rodent studies investigating how micro- and nanoplastics affect cellular health, with a focus on potential mitochondrial impacts. Researchers found that while no study has directly targeted mitochondrial effects, several reported molecular and biochemical changes consistent with disrupted mitochondrial function, including oxidative stress. The study suggests that mitochondria may be an important but understudied target of micro- and nanoplastic toxicity.

Article Tier 2

Mitochondria as a target of micro- and nanoplastic toxicity

This review examines how micro- and nanoplastics damage mitochondria, the energy-producing structures inside cells. Studies show that plastic particles can disrupt energy production, cause harmful oxidative stress, and interfere with the cell's ability to repair or recycle damaged mitochondria. Since mitochondrial damage is linked to many chronic diseases including heart disease, neurodegeneration, and diabetes, this helps explain why microplastic exposure may have widespread health effects.

Article Tier 2

Mitochondrial stress response in lung cells triggered by the inhaled nanoplastics

This review focuses on how inhaled nanoplastic particles affect mitochondrial function in lung cells, including the activation of stress responses, disruption of energy production, and triggering of cell death pathways. Researchers found that because of their extremely small size, nanoplastics can penetrate deep into lung tissue and interact directly with cellular components in ways larger particles cannot. The study highlights the lungs as a particularly vulnerable site for nanoplastic-related health effects.

Article Tier 2

Mitochondria as a target of micro- and nanoplastic toxicity

This review examines how micro- and nanoplastics damage mitochondria, the energy-producing structures inside our cells. Research shows these tiny plastic particles can cross biological barriers, enter cells, and disrupt mitochondrial function by triggering oxidative stress and altering energy production. Since mitochondrial damage is linked to diseases like cancer, diabetes, and neurodegeneration, this represents a key concern for human health.

Share this paper